Abstract
The seroprevalence of HTLV-I/II was evaluated in 1247 Italian individuals at high risk for HIV infection. The population studied consisted of 985 intravenous drug users (IVDUs), 474 of whom on methadone maintenance and 511 in a therapeutic community, 110 HIV-infected patients in various stages of HIV-related disease and 152 hemophiliacs. Sera were screened for antibody to HTLV-I/II by enzyme immunoassay (EIA) and confirmed by Western blot and radioinununoprecipitation assay. Confirmed positive samples were further differentiated by EIA using HTLV-I and HTLV-II specific peptides. The overall prevalence of anti-HTLV-I/II was 4.0% in IVDUs, with the highest prevalence (8.2%) among HIV-infected symptomatic patients. None of the hemophiliacs was antiHTLV-I/II positive, even though 63.1% tested positive for HIV antibodies. The trend of seroprevalence in drug users and the evaluation of possible risk factors demonstrated that HTLV-I/II infection has been present in Italy before the onset of HIV epidemic. The overall seroprevalence showed no significant changes during the 10 year period covered by this survey but correlated with HIV seropositivity, age and duration of drug use. Peptide testing showed that HTLV infection was mainly due to HTLV-II.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blattner W.A.,Kalyanaraman V.S.,Robert-Guroff M.,Lister T.A.,Galton D.A.G.,Salin P.S.,Crawford M.H.,Catovsky D.,Greaves M. andGallo R.C. (1982): The human type C retrovirus, HTLV, in blacks from the Caribbean region and relationship to adult T-cell leukemia/lymphoma - Int. J. Cancer.30: 257–264.
Canavaggio M.,Leckie G.,Allain J.P.,Steaffens J. W.,Laurian Y.,Brettler D. andLee H. (1990): The prevalence of antibody to HTLV-I/II in United States plasma donors and in United States and French hemophiliacs - Transfusion30: 780–782.
De Rossi A.,Bortolotti F.,Cadrobbi P. andChieco-Bianchi L. (1988): Trends of HTLV-I and HIV infections in drug addicts - Eur. J. Cancer Clin. Oncol.24: 279–280.
Ehrlich G.D.,Dowey F.R.,Kirshner J.J.,Sninsky J.J.,Kwok S.,Slamon D.J.,Kalish R. andPoiesz B.J. (1989): A polyclonal CD4+ and CD8+ lymphocytosis in a patient doubly infected with HTLV-I and HIV-1: a clinical and molecular analysis - Am. J. Hematol.30: 128–133.
Gessain A.,Barin F. andVernant J.C. (1985): Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis - Lancetii: 407–410.
Hinuma Y.,Nagata K.,Hanoaka M.,Nakai M.,Matsumoto T.,Kinoshita K.,Shirakawa S. andMiyoshi I. (1981): Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera - Proc. Natl. Acad. Sci. USA78: 6476–6480.
Hinuma Y.,Komoda H.,Chosa T.,Kondo T.,Kohakura H.,Takenaka T.,Kikuchi M.,Ichimaru M.,Yunaki K.,Matsuo R.,Takichi Y.,Uchino H. andHanoaka M. (1982): Antibodies to adult T-cell leukemia virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nationwide sero-epidemiologic survey - Int. J. Cancer29: 631–635.
Hyelle B.,Mills R.,Swenson S.,Mertz G.,Jkey C. andAllen S. (1991): Incidence of hairy cell leukemia, mycosis fungoides and chronic lymphocytic leukemia in first known HTLV-11-endemic population - J. Infect. Dis.163: 435–440.
Kueffler P.R. andBunn P.A. (1986): Adult T-cell leukemia/lymphoma - Clinics in Haematology15: 695–726.
Lairmore M.D.,Jacobson S.,Gracia F.,De B.K.,Castillo L.,Larreategui M.,Roberts B.D.,Levine P.H.,Blattner W.A. andKaplan J.E. (1990): Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indian in Panama - Proc. Natl. Acad. Sci. USA87: 8840–8844.
Lee H.,Swanson P.,Shorty V.S.,Zack J.A.,Rosenblatt J.D. andChen I.S. (1989): High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans - Science244: 471–475.
Lee H.,Weiss S.H.,Brown L.S.,Mildvan D.,Shorty V.S.,Saravolatz L.,Chu A.,Ginzburg H.M.,Markowitz N.,DesJarlais D.C.,Blattner W.A. andAllain J.P. (1990): Patterns of HIV-1 and HTLV-1/11 in intravenous drug abusers from the Middle Atlantic and Central regions of the USA - J. Infect. Dis.162: 347–352.
Manca N.,Caruso A.,Bonfanti C.,Savoldi E.,LiVigni R.,Pirali F.,Sapelli P.L. andTurano A. (I989): HTLV-I seroprevalence in AIDS patients and in HIV-I seropositive and seronegative subjects at risk for AIDS in Northern Italy - Eur. J. Epidemiol. 5;1: 37–41.
Mortimer P.P.,Vandervelde E.M.,Jesson W.J.,Pereira M.S. andBurkhardt F. (1985): HTLV-II antibody in Swiss and English intravenous drug abusers - Lancetii: 449–450.
Osame M.,Usuku K.,Izumo S.,Ijichi N.,Amitani H.,Igata A.,Matsumoto M. andTara M. (1986): HTLV-I associated myelopathy, a new clinical entity - Lanceti 1031–1032.
Poiesz B.J.,Ruscetti F. W.,Gazdar A.F.,Bunn P.A.,Minna J.D. andGallo R.C. (1980): Detection and isolation of a type-C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma - Proc. Natl. Acad. Sci. USA77: 7415–7419.
Rosenblatt J.D.,Golde D. W.,Wachsman W.,Jacobs A.,Schmidt G.,Quan S.,Gasson J.C. andChen L.S.Y. (1986): A second HTLV-II isolate associated with atypical hairy-cell leukemia - N. Engl. J. Med.315: 372–375.
Saxinger C.,Blattner W.A.,Levine P.H.,Clark J.,Biggar R.,Hoh M.,Maghissi J.,Jacobs P.,Wilson P.,Wilson L.,Jacobson R.,Crookes R.,Strong M.,Ansari A.A.,Dean A.G.,Nkrumah F.K.,Mourilli N. andGallo R.C. (1984): Human T-cell leukemia virus (HTLV-I) in Africa - Science225: 1473–1476.
Shih J., O'Donnel D., Delaney S., Mann T. andLee H. (1991): Differentiation of HTLV-I from HTLV-II using synthetic peptides from immunodominant regions of HTLVenv proteins - Transfusion31 (Supplement): 8S.
TittiF.,RezzaG.,VeraniP.,ButtòS.,SernicolaL.,RapicettaM.,SarrecchiaB.,OlivaC. andRossiG.B. (1988): HIV, HTLV-I and HBV infections in a cohort of Italian intravenous drug abusers: analysis of risk factors - J. Acquir. Immune Defic. Syndr.1: 405–411.
World Health Organization (1990): Acquired immunodeficiency syndrome (AIDS). Proposed WHO criteria for interpreting results from Western blot assay for HIV-1, HIV-2 and HTLV-I/II - Wkly Epidem. Rec.65: 281–288.
Zella D.,Morri L.,Sala M.,Ferrante P.,Casoli C.,Magnani C.,Achilli G.,Cattaneo E.,Lori F. andBertazzoni U. (1990): HTLV-II infection in Italian drug abusers - Lancetii: 575–576.
Author information
Authors and Affiliations
Additional information
Corresponding author.
Rights and permissions
About this article
Cite this article
Zanetti, A.R., Zehender, G., Tanzi, E. et al. HTLV-II among Italian intravenous drug users and hemophiliacs. Eur J Epidemiol 8, 702–707 (1992). https://doi.org/10.1007/BF00145387
Issue Date:
DOI: https://doi.org/10.1007/BF00145387